1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Investigación quirúrgica en urología y trasplante renal

Investigación quirúrgica en urología y trasplante renal

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Willisch P, Vázquez-Barreiro B, Plata A, Belmonte IC, Guardia G, Del Castillo-Acuña R, Francolini G, Franzese C, Henríquez JDS, Couñago F, López-Campos F.

    Androgen receptor pathway inhibitor intensification in non-metastatic hormone-sensitive prostate cancer: current evidence and clinical implications.

    Clinical & Translational Oncology . : .

    [doi:10.1007/s12094-026-04350-4]

  • Molina-Cerrillo J, Alonso-Gordoa T.

    Re: Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney Cancer.

    EUROPEAN UROLOGY . : .

    [doi:10.1016/j.eururo.2026.04.007]

  • Falcón A, Cote GM, Molina-Cerrillo J, Le Cesne A, Rocha P, Bockorny B, Paez D, Martin-Broto J, Chawla SP, Martinez S, Kahatt C, Alfaro V, Siguero M, Jimenez J, Custodio A, Alonso-Orduña V, López C, Kollár A, Soto-Castillo JJ, Paz-Ares L.

    Pooled safety analysis of lurbinectedin plus irinotecan in patients with advanced solid tumors.

    INVESTIGATIONAL NEW DRUGS . : .

    [doi:10.1007/s10637-026-01616-0]

  • Fernández-Conejo G, González Álvarez C, Del Olmo Durán P, Tagalos Muñoz A, Sanz Mayayo E, Diez Nicolás V, García Barreras S, Subiela Henríquez JD, Rodríguez-Patrón R, Pérez-Fernández E, Gómez Dos Santos V, Burgos Revilla FJ.

    Learning curve of Versius-assisted radical prostatectomy: role of prior experience and proctoring.

    BJU INTERNATIONAL . : .

    [doi:10.1111/bju.70405]

  • Jonsson G, Oliveira T, Hofmann M, Lemberger U, Stejskal K, Krššáková G, Sakic I, Novatchkova M, Mereiter S, Grabmann G, Köcher T, Koglgruber R, Kikic Z, Camano Páez S, Luna Sanchez B, Díez Nicolás V, Rechberger GN, Züllig T, Hagelkruys A, Englinger B, Schmidinger M, Penninger JM.

    Urinary multi-omics reveal non-invasive diagnostic biomarkers in clear cell renal cell carcinoma.

    EMBO Molecular Medicine . : .

    [doi:10.1038/s44321-026-00498-2]

  • Chernysheva D, Gómez Gómez E, Burgos Revilla J, Fernández Conejo G, García Barreras S, Linares Espinós E, Gómez Villanueva A, Domínguez Esteban M, Mera Errasti A, Breda A, Fanti S, Bjartell A, Padhani AR, Sanguedolce F.

    Imaging modalities in advanced prostate cancer: Interim analysis of the Spanish cohort of the RING registry.

    Actas Urologicas Espanolas . : 502057-502057.

    [doi:10.1016/j.acuroe.2026.502057]

  • Herrera-Martínez Y, Gómez-Bermejo MÁ, Araujo-Castro M, Minguez-Ojeda C, Galvez-Moreno MA, Molina Puerta MJ, Herrera-Martínez AD.

    Differences in Body Composition in Patients with Pheochromocytomas and Age- and Sex-Matched Non-Functioning Adrenal Tumors: A Matched Cohort Study.

    Endocrine Practice . : .

    [doi:10.1016/j.eprac.2026.08.007]

  • Rescigno P, Taha T, Fita MJ, Matthews D, Fujita K, Lolli C, DI Costanzo F, Juárez A, Ürün Y, Yazgan SC, Li H, Facchini G, Quiroga MN, Sammarco E, Bögemann M, Santini D, Baranseh J, Roviello G, Kopp RM, Fiala O, Büttner T, Carrozza F, Ansari J, Tural D, Conteduca V, Molina-Cerrillo J, Alonso-Gordoa T, Bourlon MT, Palacios GA, Paolieri F, Zgura A, DI Rocco R, Lacerenza LG, Matrana MR, Martignetti A, Massari F, Soares A, Monteiro FS, Bastos DA, Gaughan L, Wenzel M, Mandel P, Banna GL, Santoni M.

    Darolutamide versus abiraterone acetate-based triplets in patients with hormone-sensitive prostate cancer: real-world, head-to-head comparison from the ARON-3 study.

    Minerva Urology and Nephrology . : .

    [doi:10.23736/S2724-6051.26.06453-0]

  • Rizzo M, Buti S, Fiala O, Incorvaia L, Molina-Cerrillo J, Bourlon MT, Fukuokaya W, Urabe F, Park SH, Mayrhofer K, Pichler R, Niedersuess-Beke D, Taha T, Büttner T, Bamias A, Seront E, Santini D, Stumbo L, Rodriguez-Vida A, Massari F, Monteiro FSM, Soares A, Grande E, Santoni M.

    Baseline Disease Characteristics and Platinum Sensitivity as Predictors of Outcomes in Sequential Therapy with Platinum-Based Chemotherapy, Avelumab Maintenance, and Enfortumab Vedotin in Advanced Urothelial Carcinoma (ARON-2EV Study).

    Targeted Oncology . : .

    [doi:10.1007/s11523-026-01238-9]

  • Maiorano BA, Maruzzo M, Slusarczyk A, Subiela JD, Soria F, Albisinni S, Mari A, Claps F, Contieri R, Gallioli A, Caño-Velasco J, D'Andrea D, Laukhtina E, Marcq G, Krajewski W, Grobet-Jeandin E, Afferi L, Del Giudice F, Rizzo A, Moschini M, Mertens LS, Cigliola A, Mercinelli C, Piacentini M, Santoni M, Pradère B, Necchi A.

    Comparative efficacy of perioperative systemic therapies for muscle-invasive bladder cancer: a network meta-analysis of randomized trials.

    ESMO Open . 11(8): 108329-108329.

    [doi:10.1016/j.esmoop.2026.108329]

  • Slusarczyk A, Moschini M, Krajewski W, Scilipoti P, Contieri R, Claps F, Subiela JD, Mertens LS, Mori K, Velasco JC, Soria F, Grobet-Jeandin E, Tully K, Garbas K, Del Olmo Durán P, Lijnen RAG, Fertitta G, Reynard M, Katzendorn O, Puentedura AL, Longoni M, D'Andrea D, Del Giudice F, Gallioli A, Laukhtina E, Marcq G, Mari A, Afferi L, Albisinni S, Amodeo A, Boorjian SA, Briganti A, Montorsi F, Shariat SF, Gontero P, Radziszewski P, Pradere B.

    Predicting the Development of BCG-unresponsive Disease Among Patients with High-grade Non-muscle-invasive Bladder Cancer: An International Multicenter Analysis.

    European Urology Oncology . : .

    [doi:10.1016/j.euo.2026.06.005]